Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Page 1
| Issued: 1 July 2008 at 11:00 |
Ref: MDA/2008/046
|
|
|
Immediate action |
|
Action |
|
|
Update |
|
|
Information request |
| Device: Lancing devices (used in pharmacy settings) – all brands. |
|||||||||||
| Problem: Risk of transmission of blood borne infections between patients if a lancing device is used for multiple patient testing, contrary to the manufacturer's instructions for use. |
> Page 2 |
||||||||||
| Action by: Pharmacy staff involved in capillary blood sample collection using lancing devices. |
|||||||||||
|
Action:
or
Do not use:
|
> Page 2 |
||||||||||
|
Distributed to:
* via CE Bulletin |
> Page 2 |
||||||||||
| Contacts: Details of contacts for technical and clinical aspects. Change of address or removal from address list for Healthcare Commission. |
> Page 3 |
|
Action deadlines for the Safety Alert Broadcast System (SABS)
|
|
|
Deadline (action underway): 1 August 2008
|
Deadline (action complete): 1 September 2008
|
MDA/2008/046 - Lancing devices (used in pharmacy settings) – all brands. 
